Projects per year
Search results
-
Active
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy
1/1/23 → 12/31/25
Project: Federal Funding Agencies
-
Imaging for Precision Medicine in Alzheimer's Disease and Related Disorders
Masdeu, J. C., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O., Pascual, B. & Roman, G. C.
5/25/22 → …
Project: Clinical Trial
-
Regulatory T cells as a novel therapeutic target in Alzheimer's Disease
Appel, S. H., Faridar, A. & Masdeu, J. C.
8/1/21 → 12/31/24
Project: Non Profit
-
Houston Alzheimer Disease Study
Masdeu, J. C., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O., Pascual, B., Roman, G. C., Toledo, J. B. & Wong, S. T.
5/17/21 → …
Project: Clinical Trial
-
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Toledo, J. B., Faridar, A., Masdeu, J. C., Nakawah, M. O. & Pascual, B.
3/12/21 → …
Project: Clinical Trial
-
Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of AL001 in FTD (AL001-3) (INFRONT-3)
Masdeu, J. C., Faridar, A. & Pascual, B.
10/20/20 → …
Project: Clinical Trial
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Madan, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
18F-MK-6240 Tau PET and Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O., Pascual, B. & Roman, G. C.
10/29/19 → …
Project: Clinical Trial
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Pascual, B., Faridar, A. & Masdeu, J. C.
9/15/19 → 6/30/24
Project: Non Profit
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
Glutathione in Mild Cognitive Impairment
Masdeu, J. C., Faridar, A. & Pascual, B.
8/6/18 → …
Project: Clinical Trial
-
-
Role of Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O. & Pascual, B.
2/7/18 → …
Project: Clinical Trial
-
LONGITUDINAL EARLY ONSET ALZHEIMERâ??S DISEASE (LEADS)
Masdeu, J. C., Faridar, A., Nakawah, M. O. & Pascual, B.
9/15/17 → 5/31/24
Project: Non Profit
-
NMDA Receptor in Psychosis: Specific Auto-Antibodies
Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, B. & Toledo, J. B.
11/14/16 → …
Project: Clinical Trial
-
Neuroimaging in AD
Masdeu, J. C., Faridar, A., Karmonik, C., Nakawah, M. O., Pascual, B., Roman, G. C., Taffet, G. & Toledo, J. B.
9/15/16 → …
Project: Clinical Trial
-
PBR28 PET
Masdeu, J. C., Appel, S. H., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O. & Pascual, B.
6/7/16 → …
Project: Clinical Trial
-
Finished
Characterizing Adaptive Immune Mechanism in Alzheimer: a Key to Therapy
7/1/19 → 8/30/21
Project: Non Profit